NCT03103711

Brief Summary

The aim of this study is to analyze the effect of a brief psychological intervention supported by Information and Communication Technologies, on the subjective well-being of hospitalized cancer patients. Participants are randomly assigned to one of 2 conditions: Intervention condition (4 Virtual reality sessions) and Control condition (waiting list control group).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Jul 2010

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
5.3 years until next milestone

First Submitted

Initial submission to the registry

March 21, 2017

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 6, 2017

Completed
Last Updated

April 6, 2017

Status Verified

March 1, 2017

Enrollment Period

1.4 years

First QC Date

March 21, 2017

Last Update Submit

March 31, 2017

Conditions

Keywords

Virtual realityWell-beingHospital

Outcome Measures

Primary Outcomes (2)

  • The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983; adapted version of Tejero, Guimerá, Farré & Peri, 1986)

    change from baseline at 1 week

  • Fordyce Happiness Scale (Fordyce, 1988).

    change from baseline at 1 week

Secondary Outcomes (5)

  • Visual Analog Scale: Mood.

    4 days along 1 week

  • Visual Analog Scale: Emotional State. Change from pre to post session.

    4 days along 1 week

  • Visual Analog Scale: Physical Discomfort. Change from pre to post session.

    4 days along 1 week

  • Visual Analog Scale: Satisfaction with the Session Scale.

    4 days along 1 week

  • Satisfaction with Intervention Scale (adapted version of Borkovec and Nau's, 1972)

    1 week

Other Outcomes (4)

  • The Brief Illness Perception Questionnaire (BIPQ) (Broadbent et al., 2006)

    baseline

  • Personal meaning of the illness (ad-hoc).

    baseline

  • Visual Analog Scale: Optimism

    baseline

  • +1 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

The entire intervention is composed by four 30 minutes sessions along 1 week. Its focus is on the promotion of well-being by the use of two virtual environments ("Emotional Parks" and "Walk through Nature"). These environments allow participants to involve in different exercises (working with self statements, videos, images, slow breathing, focus on the present exercises) with the purpose of increase positive emotional states.

Behavioral: Virtual Reality Intervention

Control

NO INTERVENTION

Participants receive the medical treatment deliver by the hospital. They fulfill several questionnaires at two moments (pre and post 1 week after). After this, they have the possibility to receive the psychological intervention.

Interventions

Participants receive two sessions oriented to joy and two focused on relax. In the first 2 sessions patients can choose the environment ("Emotional Parks" or "Walk through Nature") and in the following ones participants visit the alternate environments.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults with any cancer diagnosis
  • hospitalized for at least 1 week
  • Karnofsky functional state ≥50
  • life expectancy ≥2 months

You may not qualify if:

  • serious psychopathology
  • cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

March 21, 2017

First Posted

April 6, 2017

Study Start

July 1, 2010

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

April 6, 2017

Record last verified: 2017-03